Literature DB >> 10921940

Relative abundance of oligosaccharides in Candida species as determined by fluorophore-assisted carbohydrate electrophoresis.

T L Goins1, J E Cutler.   

Abstract

Fluorophore-assisted carbohydrate electrophoresis (FACE) is a straightforward, sensitive method for determining the presence and relative abundance of individual oligomannosyl residues in Candida mannoprotein, the major antigenic determinant located on the outer surface of the yeast cell wall. The single terminal aldehydes of oligomannosyl residues released by hydrolysis were tagged with the charged fluorophore 8-aminonaphthalene-1,3,6-trisulfonate (ANTS) and separated with high resolution on the basis of size by polyacrylamide gel electrophoresis. ANTS fluorescence labeling was not biased by oligomannoside length; therefore, band fluorescence intensity was directly related to the relative abundance of individual oligomannoside moieties in heterogeneous samples. FACE analysis revealed the major oligomannosides released by acid hydrolysis and beta-elimination of Fehling-precipitated mannan from Candida albicans, which were the same as those previously reported in studies based on mass and nuclear magnetic spectroscopic analysis. FACE was also amenable to the analysis of samples obtained by direct hydrolysis of whole yeast cells. Whole-cell acid hydrolysis and whole-cell beta-elimination of two isolates each of C. albicans, C. glabrata, C. krusei, C. lusitaniae, C. parapsilosis, C. rugosa, C. stellatoidea, and C. tropicalis resulted in oligomannoside gel banding patterns that were species and strain specific for the 16 isolates surveyed. Whereas some bands were specific for an individual isolate or species, other bands were shared by two or three species in various groupings. Differences in the mannoprotein composition of C. albicans A9 and four spontaneous cell surface mutants were also detected. Mannan "fingerprints," or banding pattern profiles, derived from the electrophoretic mobilities of individual bands relative to the migration of acid-hydrolyzed dextran (relative migration index) yielded profiles characteristic of individual isolates not revealed by standard assimilation and biochemical profiles. FACE represents an accessible, sensitive, and quantitative analytical tool enabling the characterization of yeast mannan complexity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10921940      PMCID: PMC87130     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  48 in total

1.  Wall mannoproteins of the yeast and mycelial cells of Candida albicans: nature of the glycosidic bonds and polydispersity of their mannan moieties.

Authors:  M V Elorza; A Marcilla; R Sentandreu
Journal:  J Gen Microbiol       Date:  1988-08

2.  Dimorphism in Candida albicans: contribution of mannoproteins to the architecture of yeast and mycelial cell walls.

Authors:  M V Elorza; A Murgui; R Sentandreu
Journal:  J Gen Microbiol       Date:  1985-09

Review 3.  Protein glycosylation in yeast.

Authors:  M A Kukuruzinska; M L Bergh; B J Jackson
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

4.  Analysis of oligosaccharides by gel filtration.

Authors:  K Yamashita; T Mizuochi; A Kobata
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

5.  Immunochemical study on the mannans of Candida albicans NIH A-207, NIH B-792, and J-1012 strains prepared by fractional precipitation with cetyltrimethylammonium bromide.

Authors:  N Shibata; T Ichikawa; M Tojo; M Takahashi; N Ito; Y Okubo; S Suzuki
Journal:  Arch Biochem Biophys       Date:  1985-12       Impact factor: 4.013

6.  Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody.

Authors:  Y Han; M H Riesselman; J E Cutler
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

7.  Structural analysis of phospho-D-mannan-protein complexes isolated from yeast and mold form cells of Candida albicans NIH A-207 serotype A strain.

Authors:  N Shibata; S Fukasawa; H Kobayashi; M Tojo; T Yonezu; A Ambo; Y Ohkubo; S Suzuki
Journal:  Carbohydr Res       Date:  1989-04-15       Impact factor: 2.104

8.  Characterization of phosphomannan-protein complexes isolated from viable cells of yeast and mycelial forms of Candida albicans NIH B-792 strain by the action of Zymolyase-100T.

Authors:  N Shibata; H Kobayashi; M Tojo; S Suzuki
Journal:  Arch Biochem Biophys       Date:  1986-12       Impact factor: 4.013

9.  Presence of human antibodies reacting with Candida albicans O-linked oligomannosides revealed by using an enzyme-linked immunosorbent assay and neoglycolipids.

Authors:  M P Hayette; G Strecker; C Faille; D Dive; D Camus; D W Mackenzie; D Poulain
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

10.  Variable expression of a surface determinant during proliferation of Candida albicans.

Authors:  W L Chaffin; J Skudlarek; K J Morrow
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

View more
  22 in total

1.  Beta-1,2-mannosylation of Candida albicans mannoproteins and glycolipids differs with growth temperature and serotype.

Authors:  P A Trinel; T Jouault; J E Cutler; D Poulain
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

2.  Candida parapsilosis: an emerging pathogen developing its own identity.

Authors:  Joseph M Bliss
Journal:  Virulence       Date:  2015       Impact factor: 5.882

3.  Comparison of the hydrophobic properties of Candida albicans and Candida dubliniensis.

Authors:  K C Hazen; J G Wu; J Masuoka
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

4.  Innate inflammatory response and immunopharmacologic activity of micafungin, caspofungin, and voriconazole against wild-type and FKS mutant Candida glabrata isolates.

Authors:  Nicholas D Beyda; Guangling Liao; Bradley T Endres; Russell E Lewis; Kevin W Garey
Journal:  Antimicrob Agents Chemother       Date:  2015-06-22       Impact factor: 5.191

5.  Surface hydrophobicity changes of two Candida albicans serotype B mnn4delta mutants.

Authors:  David R Singleton; James Masuoka; Kevin C Hazen
Journal:  Eukaryot Cell       Date:  2005-04

6.  Cell wall mannan and cell surface hydrophobicity in Candida albicans serotype A and B strains.

Authors:  James Masuoka; Kevin C Hazen
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

7.  Muropeptide rescue in Bacillus subtilis involves sequential hydrolysis by beta-N-acetylglucosaminidase and N-acetylmuramyl-L-alanine amidase.

Authors:  Silke Litzinger; Amanda Duckworth; Katja Nitzsche; Christian Risinger; Valentin Wittmann; Christoph Mayer
Journal:  J Bacteriol       Date:  2010-04-16       Impact factor: 3.490

Review 8.  Advances in combating fungal diseases: vaccines on the threshold.

Authors:  Jim E Cutler; George S Deepe; Bruce S Klein
Journal:  Nat Rev Microbiol       Date:  2006-12-11       Impact factor: 60.633

Review 9.  Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges.

Authors:  James Masuoka
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

10.  Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis.

Authors:  Hong Xin; Sebastian Dziadek; David R Bundle; Jim E Cutler
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.